Uses of NK receptor antagonists

Details for Australian Patent Application No. 2010217615 (hide)

Owner Novartis AG

Inventors Stuetz, Anton; Wolff-Winiski, Barbara; Williamson, Lina

Agent Davies Collison Cave

Pub. Number AU-A-2010217615

PCT Pub. Number WO2010/097381

Priority 61/154,973 24.02.09 US

Filing date 23 February 2010

Wipo publication date 2 September 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/097381 Priority application(s): WO2010/097381

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010217623-IR detector system

2010217606-Compounds as bradykinin B1 antagonists